These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27567209)

  • 1. Re: Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
    Black PC; Seiler R
    Eur Urol; 2016 Dec; 70(6):1076. PubMed ID: 27567209
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations.
    Liedberg F
    Eur Urol; 2016 Aug; 70(2):400-1. PubMed ID: 27353966
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: HER2 as a Target in Invasive Urothelial Carcinoma.
    Chang SS
    J Urol; 2016 Dec; 196(6):1637-1639. PubMed ID: 27845103
    [No Abstract]   [Full Text] [Related]  

  • 4. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Advanced Small Cell Carcinoma of the Bladder: Clinical Characteristics, Treatment Patterns and Outcomes in 960 Patients and Comparison with Urothelial Carcinoma.
    Chang SS
    J Urol; 2017 Jun; 197(6):1440. PubMed ID: 28505896
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Mouse and Human Urothelial Cancer Organoids: A Tool for Bladder Cancer Research.
    Atala A
    J Urol; 2019 Oct; 202(4):664. PubMed ID: 31287759
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma.
    Black PC
    Eur Urol; 2017 Oct; 72(4):653-654. PubMed ID: 28583313
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma.
    Junker K; Ohlmann CH
    Eur Urol; 2017 Aug; 72(2):316-317. PubMed ID: 28341322
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Efficacy of High-intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base.
    Woldu SL; Lotan Y
    Eur Urol; 2016 Nov; 70(5):893. PubMed ID: 27498598
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base.
    Mathieu R; Peyronnet B; Bensalah K
    Eur Urol; 2016 Nov; 70(5):894. PubMed ID: 27497763
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Molecular Classification of Urothelial Carcinoma: Global mRNA Classification Versus Tumour-cell Phenotype Classification.
    Peeker R
    Eur Urol; 2018 May; 73(5):809-810. PubMed ID: 29273405
    [No Abstract]   [Full Text] [Related]  

  • 12. Bending the Curve of Advanced Urothelial Carcinoma.
    Geynisman DM; Plimack ER
    J Oncol Pract; 2017 May; 13(5):319-320. PubMed ID: 28489979
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoimmunotherapy in Metastatic Urothelial Carcinoma.
    Geynisman DM; Abbosh PH; Plimack ER; Zibelman M
    Eur Urol; 2018 May; 73(5):760-762. PubMed ID: 29331216
    [No Abstract]   [Full Text] [Related]  

  • 14. Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers.
    Gallioli A; Boissier R; Territo A; Breda A
    World J Urol; 2019 Sep; 37(9):1985-1986. PubMed ID: 30600353
    [No Abstract]   [Full Text] [Related]  

  • 15. Bladder cancer: uPAR expression indicates worse prognosis of urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2015 Mar; 12(3):120. PubMed ID: 25644167
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of Urothelial Bladder Cancer: Predicting the Future.
    Stadler WM
    J Oncol Pract; 2019 Aug; 15(8):429-430. PubMed ID: 31404513
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations.
    Chang SS
    J Urol; 2017 Feb; 197(2):319. PubMed ID: 28093142
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial.
    Sonpavde G; Pal S
    Eur Urol; 2016 Jul; 70(1):203. PubMed ID: 27302289
    [No Abstract]   [Full Text] [Related]  

  • 19. Bladder cancer: Targeted agents reverse chemotherapy resistance in urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2016 Sep; 13(9):494. PubMed ID: 27480945
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423-32.
    Eriksson P; Sjödahl G
    Eur Urol; 2019 Apr; 75(4):e106-e107. PubMed ID: 30522915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.